Additionally, it slows down gastric emptying and promotes satiety, contributing to weight loss
By mimicking this hormone, semaglutide helps reduce appetite and slows down the rate at which your stomach empties
Common insurance requirements beyond the BMI threshold include documented participation in a structured weight management program for 3-6 months, proof that lifestyle modifications alone were insufficient, step therapy requirements (trying cheaper medications first like metformin), and prior authorization with clinical documentation from your prescriber
Contraindications: - Personal or family history of medullary thyroid carcinoma (MTC) - Multiple Endocrine Neoplasia syndrome type 2 (MEN2) - Serious hypersensitivity to orforglipron Safety profile: Common adverse effects include nausea, diarrhea, constipation, vomiting, abdominal pain, and fatigue
The FDA has approved three GLP-1 medications for weight control: tirzepatide, semaglutide, and liraglutide